Discover how selective peptide binders of RNF43 offer new hope for Wnt signaling inhibition in cancer treatment.
Explore how ubiquitin-dependent mechanisms control Wnt receptors in cancer development, focusing on RNF43 and ZNRF3 as key regulators in tumorigenesis.
How a clever new strategy of molecular jamming is taking aim at a notoriously undruggable pathway in cancer through novel peptides targeting the β-catenin/TBL1 complex.
Exploring the critical role of RNF43 mutations in serrated colorectal neoplasia and their implications for cancer treatment.